Total Funding
53
62
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38552
Mnemo Therapeutics specializes in biotechnology and life science.
- François Gaudet: Chief Scientific Officer
- Alain Maiore: Founder & CEOPast Role: Ventech, Managing Partner and Head of Life Sciences
About the Company
Mnemo Therapeutics is a biotechnology company that offers to develop immune based therapies, including cell therapies. Its EnfiniT platform is a drug discovery engine that uses a class of antigens with a suite of technologies for tumors.
